|
|
| HL237 / Hanlim Pharma (0 Trials) |
|
| HL4130 / Handok (0 Trials) |
|
| HL5201 / Handok (0 Trials) |
|
| HL5501 / Handok (0 Trials) |
|
| HLA A1 MAGE A4 autologous SPEAR T cells / Adaptimmune (0 Trials) |
|
| HLA A24 MAGE A4 autologous SPEAR T cells / Adaptimmune (0 Trials) |
|
| HLA-A*02-restricted URLC10 peptides with adjuvant / Shiga University (0 Trials) |
|
| HLA-A*02:01 restricted MAGE-A4 TCR / Anocca (0 Trials) |
|
| HLA-A*02:01 restricted NY-ESO-1/LAGE-1A TCR-T / Anocca (0 Trials) |
|
| HLA-A*2402-restricted peptide vaccine / Shiga University (0 Trials) |
|
| HLA-A*24:02 restricted MAGE-A4 TCR / Anocca (0 Trials) |
|
| HLA-A*24:02 restricted NY-ESO-1/LAGE-1A TCR-T / Anocca (0 Trials) |
|
| HLA-B*07:02 restricted NY-ESO-1 TCR-T / Anocca (0 Trials) |
|
| HLA-B*35:01 restricted NY-ESO-1 TCR-T / Anocca (0 Trials) |
|
| HLB1-001 / Huons (0 Trials) |
|
| HLCN061 / Healios (0 Trials) |
|
| HLCR011 / Sumitomo Pharma, Healios (0 Trials) |
|
| HLX-53 / Fosun Pharma (0 Trials) |
|
| HLX04-O (bevacizumab biosimilar) / Fosun Pharma, Essex Bio-Technology (0 Trials) |
|
| HLX05 (cetuximab biosimilar) / Fosun Pharma, Jingze Biotech (0 Trials) |
|
| HLX09 / Fosun Pharma (0 Trials) |
|
| HLX11 (pertuzumab biosimilar) / Fosun Pharma, Organon (0 Trials) |
|
| HLX12 (ramucirumab biosimilar) / Fosun Pharma (0 Trials) |
|
| HLX13 (ipilimumab biosimilar) / Fosun Pharma, Organon (0 Trials) |
|
| HLX14 (denosumab biosimilar) / Fosun Pharma, Organon (0 Trials) |
|
| HLX15 (daratumumab biosimilar) / Fosun Pharma (0 Trials) |
|
| HLX22 / Fosun Pharma, AbClon, Alligator Biosci (0 Trials) |
|
| HLX23 / Fosun Pharma (0 Trials) |
|
| HLX24 / Fosun Pharma (0 Trials) |
|
| HLX26 / Fosun Pharma (0 Trials) |
|
| HLX301 / Fosun Pharma (0 Trials) |
|
| HLX304 / Fosun Pharma (0 Trials) |
|
| HLX35 / Fosun Pharma, Binacea Pharma (0 Trials) |
|
| HLX51 / Fosun Pharma (0 Trials) |
|
| HLX52 / Fosun Pharma (0 Trials) |
|
| HLX55 / Fosun Pharma (0 Trials) |
|
| HLX56 / Galaxy Biotech (0 Trials) |
|
| HLX58 / Fosun Pharma (0 Trials) |
|
| HLX59 / Fosun Pharma (0 Trials) |
|
| HLX60 / Fosun Pharma (0 Trials) |
|
| HLX63 / Fosun Pharma (0 Trials) |
|
| HLX70 / Fosun Pharma, ZJ Bio-Tech (0 Trials) |
|
| HLX71 / Fosun Pharma (0 Trials) |
|
| HM-018 / Hutchmed (0 Trials) |
|
| HM-029 / Hutchmed (0 Trials) |
|
| HM-A42 / Hutchmed (0 Trials) |
|
| HM004-6599 / Hutchmed (0 Trials) |
|
| HM15136 / Hanmi (0 Trials) |
|
| HM15910 / Hanmi (0 Trials) |
|
| HM15912 / Hanmi (0 Trials) |
|
| HM16390 / Hanmi (0 Trials) |
|
| HM5016504 / Hutchmed (0 Trials) |
|
| HM5016699 / Hutchmed (0 Trials) |
|
| HM81422 / Hanmi (0 Trials) |
|
| HM87086 / Hanmi (0 Trials) |
|
| HM87119 / Hanmi (0 Trials) |
|
| HM87277 / Hanmi (0 Trials) |
|
| HM90822 / Hanmi (0 Trials) |
|
| HM97211 / Hanmi (0 Trials) |
|
| HM97594 / Hanmi (0 Trials) |
|
| HM97662 / Hanmi (0 Trials) |
|
| HM99462 / Hanmi (0 Trials) |
|
| HMBD-001 / Hummingbird Biosci (0 Trials) |
|
| HMBD-002 / Hummingbird Biosci (0 Trials) |
|
| HMBD-004A / Hummingbird Biosci (0 Trials) |
|
| HMBD-004B / Hummingbird Biosci (0 Trials) |
|
| HMBD-009 / Hummingbird Biosci (0 Trials) |
|
| HMBD-011 / Hummingbird Biosci (0 Trials) |
|
| HMBD-501 / Endeavor BioMed (0 Trials) |
|
| HMG-3529 / Protheragen (0 Trials) |
|
| HMI-102 / Homology Medicines (0 Trials) |
|
| HMI-103 / Homology Medicines (0 Trials) |
|
| HMI-115 / Bayer, Hope Medicine (0 Trials) |
|
| HMN-176 / Nippon Shinyaku (0 Trials) |
|
| HMN-214 / Nippon Shinyaku (0 Trials) |
|
| HMPL-004 / Hutchmed (0 Trials) |
|
| HMPL-011 / Hutchmed (2 Trials) |
|
| HMPL-295 / Hutchmed (0 Trials) |
|
| HMPL-306 / Hutchmed (0 Trials) |
|
| HMPL-453 / Hutchmed (3 Trials) |
|
| HMPL-653 / Hutchmed (0 Trials) |
|
| HMPL-760 / Hutchmed (0 Trials) |
|
| HMPL-A83 / Hutchmed (0 Trials) |
|
| HMS 5678 / Hua Medicine (0 Trials) |
|
| HN-01 / China Pharmaceutical University (0 Trials) |
|
| HNC042 / Henovcom (0 Trials) |
|
| HNC1058 / Henovcom (0 Trials) |
|
| HNC1399 / Henovcom (0 Trials) |
|
| HNC664 / Henovcom (0 Trials) |
|
| HND027 / Handa Pharma (0 Trials) |
|
| HNVAC (human inactivated Influenza A (H1N1) 2009 vaccine) / Bharat Biotech (0 Trials) |
|
| HOB-071 / Hyundai Pharm (0 Trials) |
|
| HOB-075 / Hyundai Pharm (0 Trials) |
|
| Hocena (antroquinonol) / Golden Biotechnology (1 Trials) |
|
| HOKUNALIN patch (tulobuterol) / Maruho, Abbott, Nitto Denko (0 Trials) |
|
| Holoclar (GPLSCD01) / Holostem, Chiesi (0 Trials) |
|
| Hologene 17 (ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL17A1-encoding retroviral vector) / Holostem (0 Trials) |
|
| Hologene 5 (ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vector) / Holostem (0 Trials) |
|
| Hologene 7 (ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL7-encoding retroviral vector) / Holostem (0 Trials) |
|
| holybuvir (SH-229) / Nanjing Sanhome Pharma (0 Trials) |
|
| homatropine/hydrocodone / Generic mfg. (0 Trials) |
|
| Homeo-GH (single-cell-derived clonal mesenchymal stem cells) / HomeoTherapy (0 Trials) |
|
| homoharringtonine derivative (BS-HH-002.SA) / Bensheng Pharma (0 Trials) |
|
| hOMSC300 / Cytora (0 Trials) |
|
| Homspera (substance P analogue) / IR BioSci (0 Trials) |
|
| Honedra (LSTA12) / Lisata Therap (1 Trials) |
|
| honokiol liposome lyophilized powder for injection (JRF101) / Jinrui Foundation (0 Trials) |
|
| Hope (tetrahydrocannabinol/cannabidiol) / Zelira, The Children’s Hospital of Philadelphia (0 Trials) |
|
| HOR010 / Humorigin, Eden Biologics (0 Trials) |
|
| HOR020 / Humorigin (0 Trials) |
|
| HORA-PDE6B / Coave Therap (0 Trials) |
|
| HORA-RLBP1 / Coave Therap (0 Trials) |
|
| HORA-RPE65 / Coave Therap (0 Trials) |
|
| HORC010 / Humorigin (0 Trials) |
|
| HORC020 / Humorigin (0 Trials) |
|
| HORC030 / Humorigin (0 Trials) |
|
| HORC040 / Humorigin (0 Trials) |
|
| HORC050 / Humorigin (0 Trials) |
|
| Horiuchi L-Fucoidan / FCC Horiuchi (0 Trials) |
|
| Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK (3 Trials) |
|
| Hormorin (natural micronised progesterone) / Elder Pharma (0 Trials) |
|
| HORO5X / Humorigin (0 Trials) |
|
| HOT-1010 (bevacizumab biosimilar) / Outlook Therap, Shanghai Junshi Biosci (0 Trials) |
|
| HOT-3010 (adalimumab biosimilar) / Zhejiang Huahai Pharma, Viropro, Outlook Therap, Ipca Labs, Liomont, Ligand (1 Trials) |
|
| HP161 / Stainwei Biotech (0 Trials) |
|
| HP163 / 22nd Century Group (0 Trials) |
|
| HP191 / Stainwei Biotech (0 Trials) |
|
| HP518 / Hinova Pharma (0 Trials) |
|
| HP530 / Hinova Pharma (0 Trials) |
|
| HP537 / Hinova Pharma (0 Trials) |
|
| hPAM4-Cide (yttrium Y-90 clivatuzumab tetraxetan) / Gilead (0 Trials) |
|
| HPG1860 / Hepagene Therap (0 Trials) |
|
| HPG3466 / Hepagene Therap (0 Trials) |
|
| HPMA-docetaxel (RX-21101) / Ocuphire Pharma (0 Trials) |
|
| HPN-01 / Hepanova (0 Trials) |
|
| HPN-217 / Merck (MSD) (0 Trials) |
|
| HPN424 / AbbVie, Merck (MSD) (0 Trials) |
|
| HPN536 / Merck (MSD) (0 Trials) |
|
| HPN601 / Merck (MSD) (0 Trials) |
|
| HPP-404 / vTv Therapeutics (0 Trials) |
|
| HPP737 / vTv Therapeutics (2 Trials) |
|
| HPP851 / vTv Therapeutics (0 Trials) |
|
| HPP854 / vTv Therapeutics (0 Trials) |
|
| hPTH(1-34) / Corium (0 Trials) |
|
| HPV E6-specific TCR-T cells / TCRCure (0 Trials) |
|
| HPV-16/18 vaccine / Walvax (0 Trials) |
|
| HPV9 vaccine / GSK (0 Trials) |
|
| HPW-0112 / Protheragen (0 Trials) |
|
| HQK 1001 / Viracta Therap (0 Trials) |
|
| HQP8361 / Merck (MSD), Ascentage Pharma (0 Trials) |
|
| HR001 / Hrain Biotech (0 Trials) |
|
| HR021618 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HR091506 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HR17031 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HR19042 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HR20013 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRA 081025 / Perrigo Company (0 Trials) |
|
| HRS-1358 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-1780 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-2261 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-3738 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-4642 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-5965 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-7085 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-7535 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-8080 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS-9821 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS2300 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS2398 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS2543 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS4800 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS5091 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS5685 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS7415 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS9531 / Jiangsu Hengrui Pharma (0 Trials) |
|
| HRS9950 / Jiangsu Hengrui Pharma (0 Trials) |
|
| hrsACE2 / NYU Langone Medical Center, Weill Cornell Medical College (0 Trials) |
|
| hrsACE2-IgG / NYU Langone Medical Center, Weill Cornell Medical College (0 Trials) |
|
| HRX-0233 / HepaRegeniX, Netherlands Cancer Institute-Antoni van Leeuwenhoek (0 Trials) |
|
| HS-001 / Heartseed, Novo Nordisk (0 Trials) |
|
| HS-101 / HaplnScience (0 Trials) |
|
| HS-10241 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10342 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10352 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10353 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10365 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10370 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10375 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10376 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10380 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10381 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-10383 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-130 / NightHawk Biosci (0 Trials) |
|
| HS-20093 / GSK (0 Trials) |
|
| HS-20094 / Jiangsu Hansoh Pharma (0 Trials) |
|
| HS-210 / NightHawk Biosci (0 Trials) |
|
| HS-310 / NightHawk Biosci (0 Trials) |
|
| HS-401 / HaplnScience (0 Trials) |
|
| HS-510 / NightHawk Biosci (0 Trials) |
|
| HS-IT101 / Sino-Cell Biomed (0 Trials) |
|
|